Resource Center

From Ambiguity To Action: The FDA’s New Nitrosamine Guidance - Adare Pharma Solutions

Written by Adare Pharma Solutions | Jan 1, 2024 5:00:00 AM

In this presentation, Adare’s Jason Brown breaks down the FDA’s newly finalized guidance, providing a clear overview and exploring both proven and innovative techniques to minimize nitrosamine formation in your products while ensuring compliance.